Ocumension Therapeutics (HKG:1477)
Hong Kong
· Delayed Price · Currency is HKD 7.50
+0.05 (0.67%)
Apr 29, 2026, 4:08 PM HKT
Ocumension Therapeutics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 377.46 | 769.21 | 1,054 | 1,314 | 1,785 | Upgrade
|
| Short-Term Investments | 25 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 402.46 | 769.21 | 1,054 | 1,314 | 1,785 | Upgrade
|
| Cash Growth | -47.68% | -27.01% | -19.83% | -26.37% | -12.99% | Upgrade
|
| Accounts Receivable | 325.11 | 164.07 | 119.36 | 112.71 | 18.51 | Upgrade
|
| Other Receivables | 14.51 | - | - | - | 25.84 | Upgrade
|
| Receivables | 339.62 | 164.07 | 119.36 | 112.71 | 44.35 | Upgrade
|
| Inventory | 63.92 | 45.52 | 32.47 | 24.1 | 4.99 | Upgrade
|
| Other Current Assets | 145.04 | - | - | 3.9 | - | Upgrade
|
| Total Current Assets | 951.04 | 978.8 | 1,206 | 1,455 | 1,835 | Upgrade
|
| Property, Plant & Equipment | 456.61 | 451.53 | 467.65 | 448.07 | 365.86 | Upgrade
|
| Long-Term Investments | 9.07 | 12.93 | 364.15 | 95 | 272.4 | Upgrade
|
| Other Intangible Assets | 2,601 | 2,438 | 1,140 | 919.05 | 709.97 | Upgrade
|
| Other Long-Term Assets | 73.43 | 92.43 | 93.39 | 126.4 | 148.25 | Upgrade
|
| Total Assets | 4,091 | 3,974 | 3,271 | 3,044 | 3,331 | Upgrade
|
| Accounts Payable | 68.33 | 34.42 | 25.19 | 21.7 | 4.41 | Upgrade
|
| Accrued Expenses | - | 82.27 | 100.35 | 140.94 | 89.04 | Upgrade
|
| Short-Term Debt | - | - | 120 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 52.17 | 2.06 | - | - | - | Upgrade
|
| Current Portion of Leases | 10.22 | 6.84 | 12.33 | 12.29 | 4.19 | Upgrade
|
| Current Income Taxes Payable | 0.03 | 1.04 | 0.34 | 1.55 | 2.4 | Upgrade
|
| Current Unearned Revenue | 2.75 | 7.59 | 9.05 | - | - | Upgrade
|
| Other Current Liabilities | 123.26 | 20.79 | 48.02 | 71.18 | 115.82 | Upgrade
|
| Total Current Liabilities | 256.76 | 155 | 315.28 | 247.65 | 215.85 | Upgrade
|
| Long-Term Debt | 106.04 | 14.49 | - | - | - | Upgrade
|
| Long-Term Leases | 19.11 | 2.39 | 5.66 | 17.29 | 7.03 | Upgrade
|
| Long-Term Unearned Revenue | 28.3 | 28.3 | 30.09 | 30.09 | - | Upgrade
|
| Total Liabilities | 410.21 | 200.19 | 351.03 | 295.04 | 222.88 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | - | 8,844 | 7,626 | 7,511 | 7,355 | Upgrade
|
| Retained Earnings | - | -4,876 | -4,722 | -4,447 | -4,045 | Upgrade
|
| Treasury Stock | - | -0 | -0 | -0 | -0 | Upgrade
|
| Comprehensive Income & Other | 3,681 | -194.51 | 15.95 | -315.8 | -202.79 | Upgrade
|
| Total Common Equity | 3,681 | 3,774 | 2,920 | 2,749 | 3,108 | Upgrade
|
| Shareholders' Equity | 3,681 | 3,774 | 2,920 | 2,749 | 3,108 | Upgrade
|
| Total Liabilities & Equity | 4,091 | 3,974 | 3,271 | 3,044 | 3,331 | Upgrade
|
| Total Debt | 187.54 | 25.78 | 137.98 | 29.58 | 11.21 | Upgrade
|
| Net Cash (Debt) | 214.93 | 743.42 | 915.82 | 1,285 | 1,774 | Upgrade
|
| Net Cash Growth | -71.09% | -18.82% | -28.72% | -27.57% | -13.23% | Upgrade
|
| Net Cash Per Share | 0.27 | 1.09 | 1.41 | 2.03 | 2.92 | Upgrade
|
| Filing Date Shares Outstanding | 798.91 | 815.73 | 690.66 | 688.74 | 618.42 | Upgrade
|
| Total Common Shares Outstanding | 798.91 | 815.73 | 690.66 | 688.74 | 618.42 | Upgrade
|
| Working Capital | 694.28 | 823.79 | 890.35 | 1,208 | 1,619 | Upgrade
|
| Book Value Per Share | 4.61 | 4.63 | 4.23 | 3.99 | 5.03 | Upgrade
|
| Tangible Book Value | 1,080 | 1,335 | 1,780 | 1,830 | 2,398 | Upgrade
|
| Tangible Book Value Per Share | 1.35 | 1.64 | 2.58 | 2.66 | 3.88 | Upgrade
|
| Machinery | - | 394.82 | 383.13 | 93.79 | 10.1 | Upgrade
|
| Construction In Progress | - | 93.56 | 86.22 | 323.86 | 336.98 | Upgrade
|
| Leasehold Improvements | - | 15.21 | 13.49 | 9.55 | 3.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.